[Translation] Orlistat capsules developed by Shengjia (Binhai) Biomedical Technology Co., Ltd. and orlistat capsules (specification: 60 mg, trade name: Alli) licensed by GlaxoSmithKline Consumer Healthcare were tested on Chinese healthy subjects. A single-center, randomized, open-label, two-formulation, three-sequence, three-cycle, multiple-dose, crossover design bioequivalence study
考察随餐服用奥利司他胶囊的药效学特征,评价两制剂多次给药的药效学差异,同时评价两制剂是否生物等效。
[Translation] To investigate the pharmacodynamic characteristics of orlistat capsules taken with meals, to evaluate the pharmacodynamic differences between the two preparations after multiple administrations, and to evaluate whether the two preparations are bioequivalent.